BioTuesdays

Tag - EMA

Dipexium advancing EU approval strategy for Locilex

By Len Zehr With its Phase 3 program underway in the U.S., Dipexium (NASDAQ:DPRX) has begun the regulatory process with the European Medicines Agency (EMA) for its Locilex topical treatment for diabetic foot infections...